Efficacy of Structured Insulin Order

This study has been completed.
Sponsor:
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01130558
First received: May 24, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted
  Purpose

The purpose of this study is to determine whether an electronic order template for basal-bolus insulin will improve mean blood glucose in hospitalized general medical patients with poorly controlled type 2 diabetes.


Condition Intervention
Type 2 Diabetes Mellitus
Other: Diabetes Management

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Efficacy of Structured Insulin Orders in Improving Glycemic Control

Resource links provided by NLM:


Further study details as provided by Massachusetts General Hospital:

Primary Outcome Measures:
  • Mean blood Glucose [ Time Frame: 6 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • rates of glucose values less than 60 mg/dl or less than 40 mg/dl [ Time Frame: 6 days ] [ Designated as safety issue: Yes ]
  • rate of use of sliding scale insulin [ Time Frame: 6 days ] [ Designated as safety issue: No ]

Enrollment: 128
Study Start Date: March 2009
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Ordering template and education
Internal medical residents who were asked to use the insulin order template and received education about basal-bolus insulin ordering.
Other: Diabetes Management
Using electronic insulin order template for basal-bolus insulin and education
Active Comparator: Education
Internal medical residents who received education about basal-bolus insulin ordering.
Other: Diabetes Management
Using electronic insulin order template for basal-bolus insulin and education

Detailed Description:

The study randomly assigned internal medicine residents to use an electronic insulin order template plus basal-bolus ordering education versus education only. For all patients with uncontrolled type 2 diabetes treated by these physicians, mean blood glucose, rate of hypoglycemia, and rate of sliding scale insulin use were measured.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Blood glucose less than 60 mg/dl or greater than 180 mg/dl during hospital stay

Exclusion Criteria:

  • Diagnosis of Type 1 Diabetes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01130558

Locations
United States, Massachusetts
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators
Massachusetts General Hospital
Investigators
Principal Investigator: Enrico Cagliero, M.D. Massachusetts General Hospital
  More Information

No publications provided

Responsible Party: Enrico Cagliero, M.D., Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT01130558     History of Changes
Other Study ID Numbers: 2008P-0022131
Study First Received: May 24, 2010
Last Updated: May 24, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
type 2 diabetes mellitus
basal-bolus insulin
insulin ordering

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Insulin, Globin Zinc
Insulin
Hypoglycemic Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 18, 2014